Our top pick for
Building a portfolio
Veeva Systems Inc is a health information services business based in the US. Veeva Systems shares (VEEV) are listed on the NYSE and all prices are listed in US Dollars. Veeva Systems employs 4,506 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$178.76 - $325.54|
|50-day moving average||$260.85|
|200-day moving average||$278.26|
|Wall St. target price||$328.36|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$2.36|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Veeva Systems stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Veeva Systems's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Veeva Systems's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 118x. In other words, Veeva Systems shares trade at around 118x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Veeva Systems's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.0378. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Veeva Systems's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Veeva Systems's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $407.2 million.
The EBITDA is a measure of a Veeva Systems's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.5 billion|
|Operating margin TTM||25.79%|
|Gross profit TTM||$1.1 billion|
|Return on assets TTM||8.88%|
|Return on equity TTM||19.33%|
|Market capitalisation||$41.8 billion|
TTM: trailing 12 months
There are currently 1.9 million Veeva Systems shares held short by investors – that's known as Veeva Systems's "short interest". This figure is 3.1% up from 1.8 million last month.
There are a few different ways that this level of interest in shorting Veeva Systems shares can be evaluated.
Veeva Systems's "short interest ratio" (SIR) is the quantity of Veeva Systems shares currently shorted divided by the average quantity of Veeva Systems shares traded daily (recently around 1.2 million). Veeva Systems's SIR currently stands at 1.58. In other words for every 100,000 Veeva Systems shares traded daily on the market, roughly 1580 shares are currently held short.
However Veeva Systems's short interest can also be evaluated against the total number of Veeva Systems shares, or, against the total number of tradable Veeva Systems shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Veeva Systems's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Veeva Systems shares in existence, roughly 10 shares are currently held short) or 0.0136% of the tradable shares (for every 100,000 tradable Veeva Systems shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Veeva Systems.
Find out more about how you can short Veeva Systems stock.
We're not expecting Veeva Systems to pay a dividend over the next 12 months.
Over the last 12 months, Veeva Systems's shares have ranged in value from as little as $178.76 up to $325.54. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Veeva Systems's is 0.7248. This would suggest that Veeva Systems's shares are less volatile than average (for this exchange).
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva Andi, Veeva OpenData, Veeva Link, Veeva Network Customer Master, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Doctors; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009.
Everything we know about the Krispy Kreme IPO, plus information on how to buy in.
Everything we know about the Day One Biopharmaceuticals IPO, plus information on how to buy in.
Everything we know about the Enact Holdings IPO, plus information on how to buy in.
Everything we know about the Solid Power IPO, plus information on how to buy in.
Everything we know about the Paymentus Holdings IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Qiniu Limited IPO, plus information on how to buy in.
Everything we know about the Ximalaya IPO, plus information on how to buy in.
Everything we know about the Zeta Global Holdings Corp IPO, plus information on how to buy in.
Everything we know about the Paycor HCM IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.